119 related articles for article (PubMed ID: 10615005)
1. Comparison of human and porcine tissue kallikrein substrate specificities.
Del Nery E; Chagas JR; Juliano MA; Juliano L; Prado ES
Immunopharmacology; 1999 Dec; 45(1-3):151-7. PubMed ID: 10615005
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
3. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
4. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
[TBL] [Abstract][Full Text] [Related]
6. Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.
Melo RL; Barbosa Pozzo RC; Pimenta DC; Perissutti E; Caliendo G; Santagada V; Juliano L; Juliano MA
Biochemistry; 2001 May; 40(17):5226-32. PubMed ID: 11318645
[TBL] [Abstract][Full Text] [Related]
7. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins.
Chagas JR; Portaro FC; Hirata IY; Almeida PC; Juliano MA; Juliano L; Prado ES
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):63-9. PubMed ID: 7864830
[TBL] [Abstract][Full Text] [Related]
9. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
10. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
11. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.
Pimenta DC; Chao J; Chao L; Juliano MA; Juliano L
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):473-9. PubMed ID: 10191281
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides.
Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA
Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081
[TBL] [Abstract][Full Text] [Related]
14. Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl proteases.
Juliano MA; Filira F; Gobbo M; Rocchi R; Del Nery E; Juliano L
J Pept Res; 1999 Feb; 53(2):109-19. PubMed ID: 10195448
[TBL] [Abstract][Full Text] [Related]
15. Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin.
Fiedler F
Eur J Biochem; 1987 Mar; 163(2):303-12. PubMed ID: 3643848
[TBL] [Abstract][Full Text] [Related]
16. Human plasma kallikrein and tissue kallikrein binding to a substrate based on the reactive site of a factor Xa inhibitor isolated from Bauhinia ungulata seeds.
Oliva ML; Andrade SA; Batista IF; Sampaio MU; Juliano M; Fritz H; Auerswald EA; Sampaio CA
Immunopharmacology; 1999 Dec; 45(1-3):145-9. PubMed ID: 10615004
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of porcine high molecular weight kininogen by the action of porcine pancreatic kallikrein.
Mashiko H; Miyamoto K; Takahashi H
Immunopharmacology; 1999 Dec; 45(1-3):103-5. PubMed ID: 10614997
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of porcine pancreatic kallikrein.
Fiedler F; Leysath G
Adv Exp Med Biol; 1979; 120A():261-71. PubMed ID: 495315
[TBL] [Abstract][Full Text] [Related]
19. Individual reaction steps in the release of kallidin from kininogen by tissue kallikrein.
Fiedler F; Hinz H; Lottspeich F
Adv Exp Med Biol; 1986; 198 Pt A():283-9. PubMed ID: 3643712
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin.
Pimenta DC; Oliveira A; Juliano MA; Juliano L
Biochim Biophys Acta; 2001 Jan; 1544(1-2):113-22. PubMed ID: 11341921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
